四川美豐(000731.SZ):半年度淨利潤預降94.59%-95.79%
格隆匯7月11日丨四川美豐(000731.SZ)公佈2025年半年度業績預吿,1-6月公司實現歸屬於上市公司股東的淨利潤盈利700萬元-900萬元,比上年同期下降95.79%-94.59%;扣除非經常性損益後的淨利潤虧損1,050萬元-1,250萬元,比上年同期下降107.25%-108.63%;基本每股收益盈利0.013元/股-0.016元/股。
公司2025年上半年業績較去年同期下降的主要原因是受行業週期性與結構性調整疊加影響,公司主要產品銷售價格相較去年同期大幅下降,導致毛利率大幅下降所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.